Doctor of Philosophy, The Ohio State University, 2023, Biomedical Sciences
CD4+ T “helper” populations comprise a key subset of adaptive immune cells that are critical for orchestrating antigen-specific immune responses for both the clearance of pathogens and elimination of cancers. This population responds to insult-specific environmental signals, including those from cytokines, by differentiating into a number of functionally distinct subsets, which produce cytokines and interact with additional immune cells to effect their diverse functions. Of these, T follicular helper (TFH) cells are established coordinators of humoral immune responses, as they engage in bi-directional signaling with B cells, via both cell surface receptors and cytokine signals. Ultimately, this interaction is critical for the germinal center reaction, during which B cells are activated, proliferate, and are ultimately selected to support the generation of high-affinity B cell clones, and thus, high-affinity antibodies. This process is also required for the formation of long-lived plasma cell populations, which are a key part of both natural and vaccine-induced immunological memory. In contrast to this important role, TFH cells have also been implicated in autoimmune disorders, including rheumatoid arthritis, systemic lupus erythematosus, and others, for which the production of autoantibodies is a key aspect of pathogenesis. To date, the full scope of mechanisms underlying TFH cell differentiation are incompletely understood. Complicating this process, TFH cells are not comprised of a single, monolithic population, and numerous studies support the existence and function of ‘polyfunctional' TFH populations which exhibit characteristics of other CD4+ T cell subsets (recently reviewed in (1)). Thus, it will be important for TFH-focused work to identify not only shared, but also TFH-subset-specific, regulatory mechanisms. Here, I present findings regarding both cytokine- and transcription-mediated factor mechanisms by which TFH populations are regulated.
First, we ide (open full item for complete abstract)
Committee: Kenneth Oestreich Ph.D. (Advisor); Eugene Oltz Ph.D. (Committee Chair); Hazem Ghoneim Ph.D. (Committee Member); Amy Lovett-Racke Ph.D. (Committee Member); Purnima Dubey Ph.D. (Committee Member)
Subjects: Immunology; Molecular Biology